Matricelf Reports Motor Function Improvement in Preclinical Spinal Cord Injury Study

PUBT · 5d ago
Matricelf Reports Motor Function Improvement in Preclinical Spinal Cord Injury Study
  • Matricelf today reported statistically significant motor function improvements with its engineered human neural tissue in a preclinical study of chronic spinal cord injury.
  • Benefits appeared in both male and female rats, supporting a planned application to begin human clinical trials.
  • Additional functional, sensory and tissue analyses remain ongoing; the transplant has not yet been tested in humans.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Matricelf Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611051131NEWSFILECNPR____20261105_322724_1) on November 05, 2026, and is solely responsible for the information contained therein.